New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

By Nancy Lapid March 4 (Reuters) - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent new substance use ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

Research in addictions at UB has been central to efforts to combat substance use disorders in the region, with a nationwide impact. The ongoing opioid epidemic has been fueled by the inundation of ...